Expertise:
- Removable transposon-viral hybrid vectors to generate endothelial progenitor cells from somatic cells; testing their therapeutic potential in animals and humans
Dr. Solodushko designs removable transposon-viral hybrid vectors to generate endothelial progenitor cells from somatic cells and test their therapeutic potential in animals and humans. Dr. Solodushko is also working on developing of new transposon-based vectors, alternative approach to viral and naked plasmid delivery of nucleic acids.
